742 related articles for article (PubMed ID: 27729636)
1. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
Lee KB
Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
[TBL] [Abstract][Full Text] [Related]
2. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
3. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
4. INTRAHEPATIC BILIARY PROLIFERATIONS: HISTOPATHOLOGY AND POTENTIAL IMMUNOHISTOCHEMICAL MARKERS.
Hirayama AB; Mello ES; Alves VAF
Arq Gastroenterol; 2023; 60(3):393-403. PubMed ID: 37792770
[TBL] [Abstract][Full Text] [Related]
5. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
Aishima S; Kubo Y; Tanaka Y; Oda Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
Aishima S; Oda Y
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
8. Malignant Transformation Arising Within Unusual and Rare Hepatic Lesions: Fibropolycystic Disease Form of Ductal Plate Malformation and Biliary Adenofibroma.
Chua D; Chiow AKH; Ang TL; Wang LM
Int J Surg Pathol; 2018 Sep; 26(6):542-550. PubMed ID: 29464972
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma.
Terada T; Nakanuma Y
Histopathology; 1994 Aug; 25(2):143-50. PubMed ID: 7527010
[TBL] [Abstract][Full Text] [Related]
10. Intestinal type cholangiocarcinoma of intrahepatic large bile duct associated with hepatolithiasis--a new histologic subtype for further investigation.
Bae JY; Park YN; Nakanuma Y; Lee WJ; Kim JY; Park C
Hepatogastroenterology; 2002; 49(45):628-30. PubMed ID: 12063956
[TBL] [Abstract][Full Text] [Related]
11. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
12. Precancerous lesions of intrahepatic cholangiocarcinoma.
Shimonishi T; Sasaki M; Nakanuma Y
J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
[TBL] [Abstract][Full Text] [Related]
13. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
14. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection.
Joo I; Lee JM
Abdom Imaging; 2013 Dec; 38(6):1334-50. PubMed ID: 23925840
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
Xu AM; Xian ZH; Zhang SH; Chen XF
Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
[TBL] [Abstract][Full Text] [Related]
16. [Cholangiocarcinoma with bile duct adenoma and hamartoma-like lesion in the bile duct].
Takahashi S; Takada K; Kawano Y; Miyanishi K; Ishiwatari H; Hayashi T; Sagawa T; Sato T; Sato Y; Takimoto R; Kobune M; Kuroiwa G; Hirayama M; Tobioka H; Hirata K; Omatsu M; Hasegawa T; Kato J
Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):461-9. PubMed ID: 20203450
[TBL] [Abstract][Full Text] [Related]
17. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.
Tsokos CG; Krings G; Yilmaz F; Ferrell LD; Gill RM
Hum Pathol; 2016 Nov; 57():61-67. PubMed ID: 27396933
[TBL] [Abstract][Full Text] [Related]
18. Bile duct adenoma (hamartoma of peribiliary glands): Importance of an adequate diagnosis.
Fernández Fernández JM; Muriel Cueto P; Sánchez Sánchez AM; Dulanto Vargas M; Bados Nieto P
Cir Esp; 2015 Oct; 93(8):e95-6. PubMed ID: 24125022
[No Abstract] [Full Text] [Related]
19. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
20. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA
J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
